News
-
-
-
PRESS RELEASE
Qanatpharma, Zuse Institute Berlin, Enamine, and Proteros biostructures Announce Generative-AI Driven Lead Discovery Collaboration
Qanatpharma, Zuse Institute Berlin, Enamine, and Proteros biostructures collaborate on Generative-AI Driven Lead Discovery for treating brain hemorrhage complications. Research focuses on delaying cerebral ischemia. Program combines AI, drug design, compound synthesis, and hit validation -
-
